ANPEP and lung carcinoma: Increased soluble forms of APN/CD13 were also demonstrated in breast, thyroid, colorectal, ovarian, renal and lung cancer patients [18–20, 31, 32]; which indicate that APN/CD13 might have potential as a cancer-specific serum biomarker for various cancers including PC.